Acrux Ltd has released a press release.
Appendix 4C and Activities Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Acrux
- Address of Chair and CEO to AGM
- Acrux receives $2.88m R&D Tax Incentive Rebate for FY23
- Investor Presentation - Acrux FY23 Results
- Appendix 4E and FY23 Annual Report
- Activities Statement and Appendix 4C
Later from Acrux
- Appendix 4D and Half Year Accounts
- Investor Presentation Half Year Accounts
- Launch of Dapsone 5%, Gel in the United States
- Acrux presentation at Hidden Gems in Lifesciences Forum
- RDTI funding facility secured
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux